Ardelyx ARDX Business Segments — Total revenues
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Ardelyx in its filing.
Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
The official record: Ardelyx’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Ardelyx's business segments — total revenues.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Ardelyx's business segments — total revenues?
- Ardelyx (ARDX) reported business segments — total revenues of $94.47M in Q1 2026.
- How has Ardelyx's business segments — total revenues changed year-over-year?
- Ardelyx's business segments — total revenues increased by 27.5% year-over-year, from $74.11M to $94.47M.
- What is the long-term trend for Ardelyx's business segments — total revenues?
- Over 3 years (2022 to 2025), Ardelyx's business segments — total revenues has grown at a 98.4% compound annual growth rate (CAGR), from $52.16M to $407.32M.
- What does business segments — total revenues mean?
- Represents the total gross revenue generated by the company's primary business segment from the sale of pharmaceutical products and services. This figure reflects the market adoption and commercial success of the company's therapeutic portfolio. It serves as a key indicator of top-line growth and the effectiveness of commercialization strategies.